1h Free Analyst Time
Global Interventional Cardiology Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the interventional cardiology market and it is poised to grow by $ 4.40 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The reports on the interventional cardiology market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing cardiac disorders and rising older population, advances in technology, and growing demand for MI procedures. In addition, increasing cardiac disorders and rising older population is anticipated to boost the growth of the market as well.
The interventional cardiology market analysis includes product segment and geographical landscapes.
The interventional cardiology market is segmented as below:
By Product
- Coronary stents
- PTCA balloon catheters
- Interventional guidewires
- Interventional imaging systems
- Others
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the emergence of bioabsorbable stents as one of the prime reasons driving the interventional cardiology market growth during the next few years. Also, the growing popularity of hybrid procedures and focus on emerging countries will lead to sizable demand in the market.
The interventional cardiology market report covers the following areas:
- Interventional cardiology market sizing
- Interventional cardiology market forecast
- Interventional cardiology market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading interventional cardiology market vendors that include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Medtronic Plc, MicroPort Scientific Corp., Teleflex Inc., and Terumo Corp. Also, the interventional cardiology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by End-user
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Exhibit
Executive Summary
The publisher recognizes the following companies as the key players in the global interventional cardiology market: Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Medtronic Plc, MicroPort Scientific Corp., Teleflex Inc., and Terumo Corp.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the emergence of bioabsorbable stents.'
According to the report, one of the major drivers for this market is the increasing cardiac disorders and rising older population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton
- Dickinson and Co.
- BIOTRONIK SE & Co. KG
- Boston Scientific Corp.
- Cardinal Health Inc.
- Medtronic Plc
- MicroPort Scientific Corp.
- Teleflex Inc.
- Terumo Corp.